Neurobiology of DiseaseNeurosciencePeer-reviewed journal article
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2
Dylan J. Dues, Yue MaiD, An Phu Tran Nguyen, Alina V. OffermaniD, Ian BeddowsiD, Darren J. MooreiD
- Citations
- 4
- FWCI
- 0.68
- Field percentile
- top 31%
Abstract
Leucine-rich repeat kinase 2 (LRRK2) and -synuclein share enigmatic roles in the pathobiology of Parkinsons disease (PD). LRRK2 mutations are a common genetic cause of PD which, in addition to neurodegeneration, often present with abnormal deposits of -synuclein in the form of Lewy-related pathology. As Lewy-related pathology is a prominent neuropathologic finding in sporadic PD, the relationship between LRRK2 and -synuclein has garnered considerable interest. However, whether and how LRRK2 might influence the accumulation of Lewy-related pathology remains poorly understood. Through stereotactic injection of mouse -synuclein pre-formed fibrils (PFF), we modeled the spread of Lewy-related pathology within forebrain regions where LRRK2 is most highly expressed. The impact of LRRK2 genotype on the formation of -synuclein inclusions was evaluated at 1-month post-injection. Neither deletion of LRRK2 nor G2019S LRRK2 knockin appreciably altered the burden of - synuclein pathology at this early timepoint. These observations fail to provide support for a robust pathophysiologic interaction between LRRK2 and -synuclein in the forebrain in vivo. There was, however, a modest reduction in microglial activation induced by PFF delivery in the hippocampus of LRRK2 knockout mice, suggesting that LRRK2 may contribute to -synuclein-induced neuroinflammation. Collectively, our data indicate that the pathological accumulation of -synuclein in the mouse forebrain is largely independent of LRRK2. HighlightsO_LIAdult mice accumulate -synuclein pathology in the hippocampus and cortex following stereotactic injection with -synuclein PFFs, with negligible influence of LRRK2 genotype. C_LIO_LIHippocampal and cortical -synuclein pathology elicits the concomitant accrual of phosphorylated tau, reactive astrogliosis, and microglial activation. C_LIO_LIAbsence of endogenous LRRK2 attenuates microglial activation in the dorsal hippocampus induced by PFFs, but not in the entorhinal cortex. C_LIO_LIAccumulation of -synuclein inclusions and related neuropathologic changes were strongly associated across the hippocampal dorsal-ventral axis, regardless of LRRK2 genotype. C_LI
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
Charlotte F. Brzozowski, Baraa A. Hijaz, … Laura A. Volpicelli‐Daley·Acta Neuropathologica CommunicationsPeer-reviewed·Nov 8, 2021
- LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, … Aaron D. Gitler·Acta NeuropathologicaPeer-reviewed·Mar 29, 2019
- Pathologic α-Synuclein Species Activate LRRK2 in Pro-Inflammatory Monocyte and Macrophage Responses
Enquan Xu, Ravindra Boddu, … Andrew B. West·bioRxiv·May 4, 2020
- Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications
Michael Aagaard Andersen, Florence Sotty, … Kenneth Vielsted Christensen·eNeuroPeer-reviewed·Nov 1, 2019
- Widespread Distribution of α-Synuclein Oligomers in LRRK2-related Parkinson's Disease
Hiroaki Sekiya, Lukas Franke, … Dennis W. Dickson·Acta NeuropathologicaPeer-reviewed·May 2, 2025
- Rit2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathology
Julia Obergasteiger, Anne-Marie Castonguay, … Mattia Volta·bioRxiv·Oct 21, 2020